David Walker - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Fear, Learning

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Parsons RG, Walker DL, Davis M. Mechanisms underlying long-term fear memory formation from a metaplastic neuronal state. Neurobiology of Learning and Memory. PMID 27660077 DOI: 10.1016/j.nlm.2016.09.009  1
2015 Bhattacharya A, Mamcarz M, Mullins C, Choudhury A, Boyle RG, Smith DG, Walker DW, Klann E. Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26708105 DOI: 10.1038/npp.2015.369  0.36
2014 Davis M, Walker DL. Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock. Brain Structure & Function. 219: 1969-82. PMID 23934654 DOI: 10.1007/s00429-013-0616-5  1
2013 Sink KS, Davis M, Walker DL. CGRP antagonist infused into the bed nucleus of the stria terminalis impairs the acquisition and expression of context but not discretely cued fear. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 730-9. PMID 24255102 DOI: 10.1101/lm.032482.113  1
2013 Sink KS, Chung A, Ressler KJ, Davis M, Walker DL. Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors. Behavioural Brain Research. 243: 286-93. PMID 23376701 DOI: 10.1016/j.bbr.2013.01.024  1
2013 Sink KS, Walker DL, Freeman SM, Flandreau EI, Ressler KJ, Davis M. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Molecular Psychiatry. 18: 308-19. PMID 22290119 DOI: 10.1038/Mp.2011.188  1
2011 Miles L, Davis M, Walker D. Phasic and sustained fear are pharmacologically dissociable in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1563-74. PMID 21471958 DOI: 10.1038/Npp.2011.29  1
2011 Sink KS, Walker DL, Yang Y, Davis M. Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 1802-10. PMID 21289190 DOI: 10.1523/JNEUROSCI.5274-10.2011  1
2010 Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 105-35. PMID 19693004 DOI: 10.1038/Npp.2009.109  1
2009 Walker DL, Miles LA, Davis M. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1291-308. PMID 19595731 DOI: 10.1016/j.pnpbp.2009.06.022  1
2009 Walker D, Yang Y, Ratti E, Corsi M, Trist D, Davis M. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1533-42. PMID 19078950 DOI: 10.1038/Npp.2008.210  0.36
2009 Zhao Z, Yang Y, Walker DL, Davis M. Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 331-40. PMID 18418359 DOI: 10.1038/npp.2008.55  1
2008 Walker DL, Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Structure & Function. 213: 29-42. PMID 18528706 DOI: 10.1007/s00429-008-0183-3  1
2008 Walker DL, Davis M. Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learning & Memory (Cold Spring Harbor, N.Y.). 15: 67-74. PMID 18230675 DOI: 10.1101/lm.798908  1
2005 Walker DL, Paschall GY, Davis M. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression. Learning & Memory (Cold Spring Harbor, N.Y.). 12: 120-9. PMID 15774945 DOI: 10.1101/lm.87105  1
2004 Walker DL, Davis M. Are fear memories made and maintained by the same NMDA receptor-dependent mechanisms? Neuron. 41: 680-2. PMID 15003167 DOI: 10.1016/S0896-6273(04)00114-X  1
2003 Davis M, Walker DL, Myers KM. Role of the amygdala in fear extinction measured with potentiated startle. Annals of the New York Academy of Sciences. 985: 218-32. PMID 12724161 DOI: 10.1111/J.1749-6632.2003.Tb07084.X  1
2003 Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. European Journal of Pharmacology. 463: 199-216. PMID 12600711 DOI: 10.1016/S0014-2999(03)01282-2  1
2002 Walker DL, Rattiner LM, Davis M. Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behavioral Neuroscience. 116: 1075-83. PMID 12492306 DOI: 10.1037//0735-7044.116.6.1075  1
2002 Walker DL, Davis M. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology. 164: 318-28. PMID 12424556 DOI: 10.1007/s00213-002-1213-0  1
2002 Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2343-51. PMID 11896173 DOI: 10.1523/Jneurosci.22-06-02343.2002  1
2002 Walker DL, Davis M. Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology. 159: 304-10. PMID 11862363 DOI: 10.1007/s002130100913  1
2002 Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacology, Biochemistry, and Behavior. 71: 379-92. PMID 11830172 DOI: 10.1016/S0091-3057(01)00698-0  1
1997 Davis M, Walker DL, Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 352: 1675-87. PMID 9415919 DOI: 10.1098/rstb.1997.0149  0.92
1997 Walker DL, Cassella JV, Lee Y, De Lima TC, Davis M. Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle. Neuroscience and Biobehavioral Reviews. 21: 743-53. PMID 9415899 DOI: 10.1016/S0149-7634(96)00061-9  1
1997 Walker DL, Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biological Psychiatry. 42: 461-71. PMID 9285082 DOI: 10.1016/S0006-3223(96)00441-6  1
1997 Walker DL, Davis M. Involvement of the dorsal periaqueductal gray in the loss of fear-potentiated startle accompanying high footshock training. Behavioral Neuroscience. 111: 692-702. PMID 9267647 DOI: 10.1037/0735-7044.111.4.692  1
1997 Davis M, Walker DL, Lee Y. Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Annals of the New York Academy of Sciences. 821: 305-31. PMID 9238214 DOI: 10.1111/j.1749-6632.1997.tb48289.x  1
1996 Lee Y, Walker D, Davis M. Lack of a temporal gradient of retrograde amnesia following NMDA-induced lesions of the basolateral amygdala assessed with the fear-potentiated startle paradigm. Behavioral Neuroscience. 110: 836-9. PMID 8864274 DOI: 10.1037//0735-7044.110.4.836  1
1994 Walker DL, Gold PE. Intra-amygdala kinase inhibitors disrupt retention of a learned avoidance response in rats. Neuroscience Letters. 176: 255-8. PMID 7830959 DOI: 10.1016/0304-3940(94)90095-7  1
1992 Stone WS, Walker DL, Gold PE. Sleep deficits in rats after NMDA receptor blockade. Physiology & Behavior. 52: 609-12. PMID 1409928 DOI: 10.1016/0031-9384(92)90355-6  1
1991 Walker DL, Gold PE. Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory. Brain Research. 549: 213-21. PMID 1832074 DOI: 10.1016/0006-8993(91)90460-D  1
1991 Walker DL, McGlynn T, Grey C, Ragozzino M, Gold PE. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists. Psychopharmacology. 105: 57-62. PMID 1745712 DOI: 10.1007/Bf02316864  1
Show low-probability matches.